These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 15675125)
21. [Antineutrophil cytoplasmic antibodies (ANCA). Their contribution to the pathogenesis of vasculitis]. Mirapeix E Med Clin (Barc); 1998 Jun; 110(20):778-80. PubMed ID: 9666419 [No Abstract] [Full Text] [Related]
22. Towards diagnostic criteria for the ANCA-associated vasculitides. Luqmani RA Clin Exp Rheumatol; 2007; 25(1 Suppl 44):S57. PubMed ID: 17428369 [No Abstract] [Full Text] [Related]
23. Antineutrophil cytoplasmic antibodies (ANCA): diagnostic utility and potential role in the pathogenesis of vasculitis. Malenica B; Rudolf M; Kozmar A Acta Dermatovenerol Croat; 2004; 12(4):294-313. PubMed ID: 15588565 [TBL] [Abstract][Full Text] [Related]
24. Immunotherapy for antineutrophil cytoplasmic antibody-associated vasculitis: challenging the therapeutic status quo? Bosch X; Guilabert A; Espinosa G; Mirapeix E Trends Immunol; 2008 Jun; 29(6):280-9. PubMed ID: 18440274 [TBL] [Abstract][Full Text] [Related]
25. [ANCA-associated vasculitides. Classifying the disease and its activity according to EULAR/EUVAS recommendations]. Holle JU; Lamprecht P Z Rheumatol; 2009 Feb; 68(1):75-80. PubMed ID: 19093126 [No Abstract] [Full Text] [Related]
33. -463 G/A myeloperoxidase promoter polymorphism is associated with clinical manifestations and the course of disease in MPO-ANCA-associated vasculitis. Reynolds WF; Stegeman CA; Tervaert JW Clin Immunol; 2002 May; 103(2):154-60. PubMed ID: 12027420 [TBL] [Abstract][Full Text] [Related]
34. What you should know about PR3-ANCA. Evidence for the role of T cells in the pathogenesis of systemic vasculitis. Clayton AR; Savage CO Arthritis Res; 2000; 2(4):260-2. PubMed ID: 11094438 [TBL] [Abstract][Full Text] [Related]
35. Systemic small vessel vasculitis: pathophysiological aspects of antineutrophil cytoplasm antibodies (ANCA). A review on recent findings. Wiik A Autoimmun Rev; 2004 Jun; 3 Suppl 1():S51-3. PubMed ID: 15309795 [No Abstract] [Full Text] [Related]
36. Antineutrophil cytoplasmic antibodies reacting with the pro form of proteinase 3 and disease activity in patients with Wegener's granulomatosis and microscopic polyangiitis. Russell KA; Fass DN; Specks U Arthritis Rheum; 2001 Feb; 44(2):463-8. PubMed ID: 11229478 [TBL] [Abstract][Full Text] [Related]
38. Alpha-1-antitrypsin phenotyping in ANCA-associated diseases: one of several arguments for protease/antiprotease imbalance in systemic vasculitis. Esnault VL; Audrain MA; Sesboüé R Exp Clin Immunogenet; 1997; 14(3):206-13. PubMed ID: 9493789 [TBL] [Abstract][Full Text] [Related]
39. Antineutrophil cytoplasmic antibody (ANCA)-associated autoimmune diseases induced by antithyroid drugs: comparison with idiopathic ANCA vasculitides. Bonaci-Nikolic B; Nikolic MM; Andrejevic S; Zoric S; Bukilica M Arthritis Res Ther; 2005; 7(5):R1072-81. PubMed ID: 16207324 [TBL] [Abstract][Full Text] [Related]
40. Role of antineutrophil cytoplasmic antibodies and glomerular basement membrane antibodies in the diagnosis and monitoring of systemic vasculitides. Sinclair D; Stevens JM Ann Clin Biochem; 2007 Sep; 44(Pt 5):432-42. PubMed ID: 17761028 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]